A carregar...
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
OBJECTIVE: To determine the effect of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptors, on biomarkers of nonalcoholic steatohepatitis (NASH) and fibrosis in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Pa...
Na minha lista:
| Publicado no: | Diabetes Care |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7245348/ https://ncbi.nlm.nih.gov/pubmed/32291277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1892 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|